Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Belén Garijo

Belen Garijo
  • Member of the Executive Board
  • CEO Healthcare
Belén Garijo, born on July 31, 1960 in Almansa, Spain, is a Member of the Executive Board of Merck KGaA, Darmstadt, Germany, since January 2015. She is responsible for the Healthcare business sector, comprising the Biopharma, Consumer Health, Allergopharma and Biosimilars businesses. Since 2013 she also acts as President and CEO of the Biopharma business, where she started in 2011 as Chief Operating Officer.
Before joining Merck KGaA, Darmstadt, Germany, Belén Garijo was employed by Sanofi-Aventis as Senior Vice President Global Operations Europe, serving as a member of the Management Committee of the Sanofi-Aventis Group and of the Management Board of the Sanofi-Pasteur vaccines joint venture with MSD. In 2011, she took on the additional role of Global Integration Leader for the Genzyme acquisition. From 2003 to 2006, Belén Garijo was General Manager of Aventis Spain, subsequently leading the merger of Sanofi-Aventis in 2004. From 2000 to 2003 she served as Global Vice President Oncology at Aventis and from 1996 as Director of the Oncology Business Unit in the predecessor company Rhône-Poulenc Rorer.
Prior to this she worked in R&D for eight years, initially as the Medical Director of the Abbott Laboratories Spanish affiliate, before moving to lead International Medical Affairs at the Abbott headquarters in Illinois, USA.
Belén Garijo is a medical doctor, specialized in clinical pharmacology. She worked as a practicing physician for six years, before moving to the pharmaceutical industry. Belén Garijo is married and has two daughters.
Responsibility for Group functions
  • Public Affairs & Corporate Responsibility

External positions
  • L’Oréal SA, Member of the Board of Directors
  • Banco Bilbao Vizcaya Argentaria S.A., Member of the Board of Directors
  • PhRMA (Pharmaceutical Research and Manufacturers of America), Member of the Board


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.


Read more on M - The Explorer Magazine

Free-form displays in the cockpit

What was once known as the dashboard can now justifiably be called a cockpit: Our innovations for LC displays are opening up new dimensions that will also benefit automobile designers.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

More safety: Smart automotive lighting

In cooperation with industrial partners such as Hella and Porsche, we are developing a headlight system that will improve traffic safety – thanks to liquid crystals shutters for sensitive responding.

Read more on M - The Explorer Magazine